Merck KGaA (MRK):企業の財務・戦略的SWOT分析

◆英語タイトル:Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH48505FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Merck KGaA (MRK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diodes (OLED) materials and cosmetic active ingredients. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Mar 17,2021: Gilead and Merck partner to co-develop long-acting HIV treatments
Mar 16,2021: Merck brings new renewable energy to the grid through virtual power purchase agreement with Enel Green Power
Mar 04,2021: Merck KGaA, Darmstadt, Germany moves the Silicon Valley Innovation Hub to San Jose’s Intermolecular site
Mar 04,2021: Merck reports record results in a turbulent year
Mar 03,2021: GPHL and Merck build strategic partnership on business innovation and development in GBA

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Merck KGaA – Key Facts
Merck KGaA – Key Employees
Merck KGaA – Key Employee Biographies
Merck KGaA – Major Products and Services
Merck KGaA – History
Merck KGaA – Company Statement
Merck KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Merck KGaA – Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Life Science
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Middle East and Africa (MEA)
Performance
Geographical Segment: North America
Performance
R&D Overview
Merck KGaA – Corporate Strategy
Merck KGaA – SWOT Analysis
SWOT Analysis – Overview
Merck KGaA – Strengths
Merck KGaA – Weaknesses
Merck KGaA – Opportunities
Merck KGaA – Threats
Merck KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merck KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 17, 2021: Gilead and Merck partner to co-develop long-acting HIV treatments
Mar 16, 2021: Merck brings new renewable energy to the grid through virtual power purchase agreement with Enel Green Power
Mar 04, 2021: Merck KGaA, Darmstadt, Germany moves the Silicon Valley Innovation Hub to San Jose’s Intermolecular site
Mar 04, 2021: Merck reports record results in a turbulent year
Mar 03, 2021: GPHL and Merck build strategic partnership on business innovation and development in GBA
Feb 25, 2021: MERCK REPORTS Info Financial Results 2020
Feb 25, 2021: Merck to manufacture next-generation biotherapeutics for Alteogen
Feb 24, 2021: Poxel announces completion of Arbitration with Merck Serono
Feb 24, 2021: Merck and Transylvanian Institute of Neuroscience cooperate on brain-inspired Artificial Intelligence
Feb 15, 2021: Merck enhances design for sustainability framework, Offers customers data-driven insights for greener solutions
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Affiliate
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont...1)
Merck KGaA, Annual Ratios (Cont...2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Merck KGaA (MRK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Westinghouse Air Brake Technologies Corporation:企業のM&A・事業提携・投資動向
    Westinghouse Air Brake Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westinghouse Air Brake Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Neiman Marcus Group LTD LLC:戦略・SWOT・企業財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Glenmede Corporation:企業の戦略・SWOT・財務情報
    Glenmede Corporation - Strategy, SWOT and Corporate Finance Report Summary Glenmede Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Morinaga & Co., Ltd. (2201):企業の財務・戦略的SWOT分析
    Morinaga & Co., Ltd. (2201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • University of Cambridge:企業のM&A・事業提携・投資動向
    University of Cambridge - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Cambridge Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hunting PLC (HTG)-石油・ガス分野:企業M&A・提携分析
    Summary Hunting PLC (Hunting) is a provider of energy services that manufactures and distributes products for the extraction of oil and gas. The company provides products for the construction, completion, and re-completion of wellbore development, and intervention and subsea support of wellbore prod …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios SALVAT SA (SALVAT) is a pharmaceutical company with focus on the development and commercialization of innovative medicines. The company manufactures drugs in various segments such as personal healthcare, digestive / metabolism, urological conditions, ophthalmological diseases, E …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Rhino Resource Partners LP:企業の戦略・SWOT・財務情報
    Rhino Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Rhino Resource Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Portola Pharmaceuticals Inc (PTLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inh …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆